Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:37 AM
Ignite Modification Date:
2025-12-26 @ 10:37 AM
NCT ID:
NCT05343728
Eligibility Criteria:
Inclusion Criteria:
1\. Confirmed COVID-19 (Positive SARS-CoV-2 PCR test), 3. Moderate or severe symptoms (We defined moderate COVID-19 as patients with clinical signs of pneumonia with SpO2 \>93% in room air and severe COVID-19 as pneumonia with SpO2 ≤93% in room air or ventilator support requirement), and 4. The family signed the informed consent
Exclusion Criteria:
1. History of blood clotting disorders (eg, hemophilia and Von Willebrand's disease),
2. Have contraindications to the administration of anticoagulants, for example:
1. Platelet count \< 25,000
2. Has bleeding manifestations
3. History of heparin allergy or heparin-induced thrombocytopenia
3. Pregnant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05343728
Study Brief:
Protocol Section:
NCT05343728